Director Declaration

RNS Number : 0705U

Dechra Pharmaceuticals PLC

08 October 2010

 



Date: Friday, 8 October 2010

Dechra Pharmaceuticals plc

("Dechra")

Director's Declaration

In accordance with Listing Rule 9.6.14 (2) Dechra Pharmaceuticals plc announces that Ian Page, Chief Executive of Dechra, has been appointed as Non-Executive Chairman of Sanford DeLand Asset Management Limited with effect from 7 October 2010.

Further information:

Zoe Goulding, Company Secretary

Telephone Number: 01782 771100

NOTES:

Sanford DeLand Asset Management Limited (SDL) is an independent management company, established in March 2010.

SDL is an Appointed Representative of Castlefield Investment Partners LLP (Castlefield), which is a Manchester-based investment house with over £100m of funds managed on behalf of clients. Castlefield is authorised and regulated by the Financial Services Authority.

SDL and Castlefield are in the process of establishing a new fund, which will apply the principles of Business Perspective Investing to its management. This is the guiding philosophy that has been adopted by successful stock market investors such as Benjamin Graham, Philip Fisher, Warren Buffett and Charlie Munger, among others. It is widely acknowledged as one of the most successful long term investment strategies.

Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

RDNBLBDGSXGBGGR